The Medical Solutions (IV Fluids) Factory project represents a strategic and vital investment that addresses the growing needs of the national healthcare sector. It relies on the latest technologies and automated production lines to manufacture and fill intravenous and medical solutions according to the highest global standards of quality, sterilization, and safety, while offering competitive prices locally and regionally.
The factory aims to meet the accelerating demand in hospitals, healthcare centers, and laboratories, driven by population growth, expanding medical infrastructure, and increased health awareness. This ensures self-sufficiency and reduces dependence on imports for this essential pharmaceutical product.
The project also allows for exporting surplus production to neighboring markets, enhancing foreign currency inflows and elevating the country’s status as a regional hub for high-quality pharmaceutical industries.
Thus, the project combines the potential for sustainable and rewarding financial returns with support for national initiatives to localize pharmaceutical manufacturing, strengthen national pharmaceutical security, and become a cornerstone in enhancing the efficiency of the healthcare system and ensuring the continuous availability of high-quality medical solutions at reasonable costs.
The global intravenous (IV) solutions market was estimated at approximately USD 13.9 billion in 2024, with expectations to reach USD 29.6 billion by 2034, achieving a compound annual growth rate (CAGR) of 8% during the 2025–2034 period.
This rapid growth is driven by increasing cases of chronic diseases and malnutrition, rising demand for care in intensive care units and neonatal units, and the growing elderly population requiring IV therapy due to difficulties with oral nutrition and dehydration. Additionally, improvements in healthcare infrastructure in emerging markets, expanded investments in the medical sector, and the increasing reliance on IV solutions for post-surgical treatments and emergency care contribute to making this market one of the most vital and sustainable segments in the medical industry over the long term.
Read here: Health Sector Report in the Kingdom of Saudi Arabia
The medical supplies market in the Kingdom of Saudi Arabia was valued at approximately SAR 2.5 billion in 2025 and is expected to double to reach SAR 5 billion by 2033, reflecting strong and growing local demand and the expanding needs of the healthcare sector.
This growth aligns with Saudi Vision 2030, which pursues a strategic goal of localizing vital industries and increasing their domestic content, particularly in the healthcare field. In this context, establishing a medical solutions (IV fluids) factory represents a strategic step in line with the national direction, contributing to pharmaceutical security through stable local production of high-quality products, while reliably meeting the continuous needs of hospitals and medical centers.
The project reduces dependence on imports and ensures the availability of essential medical supplies even during crises or market fluctuations.
